WELLINGTON (XINHUA) – Researchers from the University of Auckland are calling for more research on the impact of light and noise pollution on birds’ sleeping …
Eisai to Present Latest Data on Lemborexant at The 36th Annual Sleep 2022 Meeting
TOKYO, Jun 3, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced a total of seven poster presentations including the latest data on …
Eisai Launches In-house Developed Anti-insomnia Drug Dayvigo (Lemborexant) In Hong Kong
TOKYO, Jul 1, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that its Hong Kong subsidiary Eisai (Hong Kong) Co., Ltd. …
Eisai To Present Latest Data of Lemborexant at 35th Annual Sleep Meeting (SLEEP2021)
TOKYO, Jun 9, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that a total of 5 poster presentations including the latest …
New Drug Approval for in-House Developed Anti-Insomnia Drug Dayvigo (Lemborexant) in Hong Kong
TOKYO, Mar 2, 2021 – (JCN Newswire) – Eisai Co., Ltd. announced that its Hong Kong subsidiary Eisai (Hong Kong) Co., Ltd. has obtained approval …